We are live on ! Find out more
NXL icon

Nexalin Technology

20 hedge funds and large institutions have $638K invested in Nexalin Technology in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

3.64% less ownership

Funds ownership: 7.63%3.99% (-3.6%)

5% less funds holding

Funds holding: 2120 (-1)

51% less capital invested

Capital invested by funds: $1.31M → $638K (-$669K)

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NXL Hedge Fund Activity: Q3 2025 in Review

20 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q3 2025, worth a combined $638K — down 51% from $1.31M a quarter earlier.

Fund positioning in NXL was balanced in Q3 2025: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $59K. The largest seller was MYDA Advisors, cutting an estimated $614K.

  • 20 institutional investors held Nexalin Technology (NXL) as of Q3 2025, down from 21 in Q2 2025.
  • Funds reported $638K of Nexalin Technology stock for Q3 2025, down 51% quarter-over-quarter.
  • 4 funds opened new Nexalin Technology positions in Q3 2025 and 4 closed out, a net change of 0 holders.
  • The largest Nexalin Technology buyer in Q3 2025 was Susquehanna International Group, an estimated $59K added.
  • The largest Nexalin Technology seller in Q3 2025 was MYDA Advisors, an estimated $614K sold.

Based on aggregated 13F filings for Q3 2025.